Single Anastomosis Versus Standard Duodenal Switch

Recruiting N/A Interventional Study
Obesity Morbid Obesity
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
Laval University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Bilio-Pancreatic diversion with Duodenal Switch (BPD-DS) is the most effective bariatric procedure in terms of long-term weight loss and remission rate of Type 2 Diabetes. However, its technical difficulty and increased risk of long-term nutritional deficiencies have been a major hindrance to its diffusion. Recently, a " simplified " technique of Duodenal-Switch has been proposed by Sanchez-Perna…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years and ≤60 years * Fulfill criteria for bariatric surgery as coined by National Institutes of Health BMI≥35 * Give written informed consent Exclusion Criteria: Participants who meet any of the following criteria at the time of the baseline visit are excluded from …
Contacts

Suzy Laroche

418-656-8711

suzy_laroche@ssss.gouv.qc.ca

CONTACT

Mélanie Nadeau, MSc

418-656-8711

melanie.nadeau@criucpq.ulaval.ca

CONTACT